No profile data available.
Medtronic plc (MDT) is a healthcare company in the various healthcare equipment manufacturing industry, based in Galway, Ireland, with about 95,000 full-time employees.
It reported revenue of $33.54 billion for fiscal year 2025, up 3.6% from fiscal year 2024, and net income of $4.66 billion. In Q1 2027 (the quarter ended July 31, 2026) revenue was $9.76 billion, up 13.7% from a year before. Its largest business segment, Cardiovascular, brought in 38% of segment revenue in fiscal year 2026; Rest of World was the largest region with 50%. Its market capitalization was $113.18 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended April 30, 2025; market data as of October 9, 2026.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Medtronic reported $33.54 billion in revenue for fiscal year 2025, up 3.6% from $32.36 billion in fiscal year 2024. In Q1 2027 revenue was $9.76 billion.
Cardiovascular, with $13.98 billion or 38% of segment revenue in fiscal year 2026. Next: Neuroscience (28%) and Medical Surgical (24%).
Rest of World: 50% of revenue by region in fiscal year 2026, followed by United States (50%).
$113.18 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Abbott Laboratories (ABT), Stryker Corporation (SYK), Boston Scientific Corporation (BSX), Becton, Dickinson and Company (BDX).